Piramal Pharma Ltd is a pharmaceutical company, providing end-to-end pharma services to customers and a portfolio of differentiated pharma products across a domestic and international distribution network. It operates under three business verticals; an integrated contract development and manufacturing (CDMO) business providing Active pharmaceutical ingredients (APIs), Finished dosage forms (FDFs), biologics, and vaccines among other products; the other two business verticals include a complex hospital generics business, and an India consumer healthcare business, selling over-the-counter products in India. Geographically, the company generates maximum revenue from North America and the rest from Europe, India, Japan, and other markets.
Kuvera gives you rich data insights and peer comparison for informed stock investment decisions. Just import your stock portfolio from your broking platform to Kuvera to track your investments and place your buy / sell orders.
1. Login to the Kuvera app or website and go to Invest section.
2. Select stocks and search for Piramal Pharma Ltd or scroll over to Piramal Pharma Ltd
3. Once you have understood its performance and financials, tap on Buy. You will be taken to your existing brokerage account for completing the transaction.
What is the Share Price of Piramal Pharma Ltd?
The share price of Piramal Pharma Ltd stocks is ₹216.50 as on 26/04/2025
What is the Market Cap of Piramal Pharma Ltd?
Market capitalization or market cap in short, is the total value of all the stocks of a particular company. Market capitalization of Piramal Pharma Ltd stock is ₹28,587.1 Cr on 26/04/2025.
In which sector / industry does Piramal Pharma Ltd operate?
Piramal Pharma Ltd operates in Healthcare / Biotechnology.
What was the revenue of Piramal Pharma Ltd?
The revenue of Piramal Pharma Ltd as of 2023 was ₹8,106.4 Cr
What is the PE ratio of Piramal Pharma Ltd?
The price-to-earnings ratio (P/E ratio) in case of stocks of a company is the ratio between its
current share price relative to its earnings per share (EPS). A high P/E ratio indicates that the stock is
overvalued in relation to the earnings (revenue) generated. P/E ratio of Piramal Pharma Ltd is
656.06 as on 26/04/2025.
What is the 52 week high price of Piramal Pharma Ltd?
The 52 week high of Piramal Pharma Ltd stock is ₹307.85.
What is the 52 week low price of Piramal Pharma Ltd?
The 52 week low of Piramal Pharma Ltd stock is ₹135.85.
Can fractional shares of Piramal Pharma Ltd be purchased?
No, you cannot buy fractional shares of Piramal Pharma Ltd, or any listed Indian company as of now.